Literature DB >> 1940468

Hyperendemic shigellosis in the United States: a review of surveillance data for 1967-1988.

L A Lee1, C N Shapiro, N Hargrett-Bean, R V Tauxe.   

Abstract

In 1988, 22,796 Shigella isolates were reported to the Centers for Disease Control, the highest number since national surveillance was begun in 1967. From 1986 to 1988, isolation rates increased from 5.4 to 10.1 per 100,000 persons. Increased isolation of Shigella sonnei, primarily among children and young women, occurred throughout the United States in a manner similar to the nationwide increase that occurred during the early 1970s. The highest rates during 1987-1988 were reported from countries with relatively high proportions of urban, ethnic ethnic minority, and poor residents, groups traditionally at high risk. The greatest percentage increases in isolation rates, however, occurred in relatively wealthy counties with predominantly white residents. Between 1967 and 1988, the proportion of Shigella species isolated from persons greater than or equal to 20 years of age increased 118%, while the proportion of the resident population in this age group increased only 16%. These data indicate a shift toward increased infection at older ages and the potential for periodic hyperendemic rates of shigellosis nationwide, which may be due to changing levels of immunity to S. sonnei.

Entities:  

Mesh:

Year:  1991        PMID: 1940468     DOI: 10.1093/infdis/164.5.894

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Molecular characteristics of Shigella spp. isolated from patients with diarrhoea in a new industrialized area of Thailand.

Authors:  M Na-Ubol; S Samosornsuk; L Von Seidlein; P Tapchaisri; M Ali; J D Clemens; W Chaicumpa
Journal:  Epidemiol Infect       Date:  2006-01-26       Impact factor: 2.451

2.  Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults.

Authors:  L F Fries; A D Montemarano; C P Mallett; D N Taylor; T L Hale; G H Lowell
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

3.  Usefulness of ribotyping in a molecular epidemiology study of shigellosis.

Authors:  M C Mendoza; M C Martín; M A González-Hevia
Journal:  Epidemiol Infect       Date:  1996-04       Impact factor: 2.451

4.  Treatment with succinic anhydride improves the immunogenicity of Shigella flexneri type 2a O-specific polysaccharide-protein conjugates in mice.

Authors:  D Pavliakova; C Chu; S Bystricky; N W Tolson; J Shiloach; J B Kaufman; D A Bryla; J B Robbins; R Schneerson
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

5.  High frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, streptomycin, chloramphenicol, and tetracycline isolated from patients with shigellosis in northeastern Brazil during the period 1988 to 1993.

Authors:  A A Lima; N L Lima; M C Pinho; E A Barros Juñior; M J Teixeira; M C Martins; R L Guerrant
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

6.  Intransal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection.

Authors:  C P Mallett; T L Hale; R W Kaminski; T Larsen; N Orr; D Cohen; G H Lowell
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

7.  Severity of diarrhea and malnutrition among under five-year-old children in rural Bangladesh.

Authors:  Farzana Ferdous; Sumon K Das; Shahnawaz Ahmed; Fahmida D Farzana; Jonathan R Latham; Mohammod J Chisti; Abu I M S Ud-Din; Ishrat J Azmi; Kaisar A Talukder; Abu S G Faruque
Journal:  Am J Trop Med Hyg       Date:  2013-07-01       Impact factor: 2.345

8.  Shigella sonnei strains isolated from U.S. summer students in Guadalajara, Mexico, from 1986 to 1992.

Authors:  E G Scerpella; J J Mathewson; H L DuPont; S K Marani; C D Ericsson
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

9.  Comparison of conjugates composed of lipopolysaccharide from Shigella flexneri type 2a detoxified by two methods and bound to tetanus toxoid.

Authors:  V Y Polotsky; J B Robbins; D Bryla; R Schneerson
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

10.  rRNA gene restriction patterns and biotypes of Shigella sonnei.

Authors:  A Nastasi; S Pignato; C Mammina; G Giammanco
Journal:  Epidemiol Infect       Date:  1993-02       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.